753 BASELINE HBsAg PREDICTS HBsAg LOSS AFTER 2 YEARS OF TREATMENT-FREE FOLLOW-UP IN CHRONIC HEPATITIS B PATIENTS TREATED WITH PEGINTERFERON alfa-2a AND ADEFOVIR by Jansen, L, Takkenberg, R.B, de Niet, A, Zaaijer, H.L, Weegink, C.J, Terpstra, V, Dijkgraaf, M.G.W, Molenkamp, R, Janssen, P.L.M, Koot, M, Rijckborst, V, Janssen, H.L.A, Beld, M.G.H.M, Reesink, H.W

Get full text

Validation of a sensitive and specific real-time PCR for detection and quantitation of hepatitis B virus covalently closed circular DNA in plasma of chronic hepatitis B patients by Takkenberg, R.B., Zaaijer, H.L., Molenkamp, R., Menting, S., Terpstra, V., Weegink, C.J., Dijkgraaf, M.G.W., Jansen, P.L.M., Reesink, H.W., Beld, M.G.H.M.

Get full text

Severe anemia in Malawian children by Calis, Job Cj, Phiri, Kamija S, Faragher, E Brian, Brabin, Bernard J, Bates, Imelda, Cuevas, Luis E, de Haan, Rob J, Phiri, Ajib I, Malange, Pelani, Khoka, Mirriam, Hulshof, Paul Jm, van Lieshout, Lisette, Beld, Marcel Ghm, Teo, Yik Y, Rockett, Kirk A, Richardson, Anna, Kwiatkowski, Dominic P, Molyneux, Malcolm E, van Hensbroek, Michaël Boele

Get full text

P.002 HCV-specific CD4+ T-cell responses in HIV-1 and HCV seroconverters are influenced by the sequence of HIV-1 and HCV infection and the outcome of previous HCV infection by van den Berg, C.H.S.B, Ruys, T.A, Nanlohy, N.M, van de Laar, T.J.W, Beld, M.G.H.M, Prins, M, van Baarle, D

Get full text

O.1.1 Development of a new real-time PCR for the detection of covalently closed circular DNA (cccDNA) in plasma of chronic hepatitis B patients by Takkenberg, R.B, Zaaijer, H.L, Menting, S, Terpstra, V, Weegink, C.J, Dijkgraaf, M.G.W, Jansen, P.L.M, Reesink, H.W, Beld, M.G.H.M

Get full text

O.1.4 Frequent HCV reinfection and superinfection among injecting drug users argues against HCV protective immunity by van de Laar, T.J.W, Molenkamp, R, van de Berg, C.H.S.B, Schinkel, J, Beld, M.G.H.M, Prins, M, Coutinho, R.A, Bruisten, S.M

Get full text

P1885 Similar early viral kinetics of hepatitis C virus genotypes 1 and 4 by Gelderblom, H.C, Zaaijer, H.L, Weegink, C.J, Jansen, P.L.M, Reesink, H.W, Beld, M.G.H.M

Get full text

P1884 Early prediction of response during high-dose interferon induction therapy in difficult-to-treat chronic hepatitis C patients by Gelderblom, H.C, Zaaijer, H.L, Weegink, C.J, Dijkgraaf, M.G.W, Jansen, P.L.M, Beld, M.G.H.M, Reesink, H.W

Get full text

Genetic variation in IL28B and treatment outcome in HBeAg-positive and -negative chronic hepatitis B patients treated with Peg interferon alfa-2a and adefovir by de Niet, A., Takkenberg, R.B., Benayed, R., Riley-Gillis, B., Weegink, C.J., Zaaijer, H.L., Koot, M., Jansen, P.L.M., Beld, M.G.H.M., Lopatin, U., Reesink, H.W.

Get full text

P.249 Recurrence or persistence of HCV RNA detectable only by TMA during antiviral therapy by Gelderblom, H.C., Zaaijer, H.L., Weegink, C.J., Reesink, H.W., Beld, M.G.H.M.

Get full text